[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346279-105":59,"doc-detail-346279-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-platform-analysis-of-the-tumor-immune-microenvironment-associated-with-breast-cancer-subtypes","Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes","","Breast cancer shows genetic and histologic heterogeneity and is shaped by the tumor microenvironment (TME). Using PAM50 molecular subtypes—Luminal A, Luminal B, Normal-like, Basal-like, and Her2-enriched—immune infiltration is linked to survival and treatment response. The study applies multiplex immunohistochemistry, single-cell RNA sequencing, and two deconvolution algorithms to map immune landscapes, revealing pronounced subtype-specific differences. Basal-like tumors display a richly infiltrated immune environment, whereas Luminal tumors are relatively depleted of T and B cells. Her2-enriched tumors show intermediate immune presence with increased NK and CD8+ T cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-platform-analysis-of-the-tumor-immune-microenvironment-associated-with-breast-cancer-subtypes/346279/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-platform-analysis-of-the-tumor-immune-microenvironment-associated-with-breast-cancer-subtypes/346279.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which immune cells were evaluated across breast cancer subtypes in the study?","Question",{"text":112,"@type":113},"The analysis included CD3+ T cells, tryptase+ mast cells, CD20+ B cells, CD68+ CD163+ macrophages, and CD66b+ granulocytes, revealing clear differences by subtype.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did immune infiltration patterns differ between Luminal, Her2-enriched, and Basal-like tumors?",{"text":117,"@type":113},"Luminal tumors were relatively deprived of T and B cells with sparse to moderate macrophage infiltration. Her2-enriched tumors showed moderate immune presence, while Basal-like tumors had a strikingly rich immune environment heavily infiltrated by T cells, B cells, and macrophages.",{"name":119,"@type":110,"acceptedAnswer":120},"What role did single-cell and deconvolution analyses play in the conclusions?",{"text":121,"@type":113},"Single-cell and deconvolution results confirmed that immune microenvironments are subtype-specific and supported observations such as increased natural killer (NK) and CD8+ T cells in Her2-enriched and Basal-like subtypes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346279,1790169658,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","RESEARCH ARTICLE     \nMulti-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes  \nLilly Anne Torlanda, b,c, Jürgen Geislerb,d, Youness Azimzadee, Astri Frafjordf, Hogne Røed Nilsenf, Linn Buerf, Jon Lømof, Øystein Garredf, Andliena Tahiria, Marianne Lyngrag, Inger Øynebråtenf, h, Alexandre Corthayf, h, Kristine Sahlbergb,c, Vessela Kristensenb, i and Xavier Tekplib,f, i   \naAkershus University Hospital, Department of Clinical Molecular Biology (EpiGen), Lørenskog, Norway; bInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; cVestre Viken HF, Department of Research and Innovation, Drammen Hospital, Drammen, Norway; dDepartment of Oncology, Akershus University Hospital, Lørenskog, Norway; eOslo Center for Biostatistics and Epidemiology, University of Oslo, Oslo, Norway; fDepartment of Pathology, Oslo University Hospital, Oslo, Norway; gDepartment of Pathology, Akershus University Hospital, Lørenskog, Norway; hHybrid Technology Hub – Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; iDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway  \nABSTRACT  \nBreast cancer is genetically and histologically heterogenous, and is influenced by a variety of factors, including the tumor microenvironment (TME) . The PAM50 subtypes; Luminal A, Luminal B, Normal-like, Basal-like and Her2-enriched, are associated with different tumor phenotypes and overall survival. The quantity and quality of immune cell infiltration in breast tumors play a key role in cancer development and progression and are associated with survival and treatment response. We used multiplex immunohistochemistry, single-cell RNA sequencing, and two deconvolution algorithms to explore the immune landscape across PAM50 subtypes. Immunostaining of CD3+ T cells, tryptase+ mast cells, CD20+ B cells, CD68+ CD163+ macrophages, and CD66b+ granulocytes revealed marked differences in tumor immune infiltrates according to breast cancer subtypes. Luminal tumors were relatively deprived of T cells and B cells, while exhibiting sparse to moderate amounts of macrophage infiltration. In contrast, Her2-enriched tumors exhibited a moderate immune presence, with sparse to moderate T cell infiltration and moderate infiltration of B cells and macrophages. At the other end of the spectrum, Basal-like tumors stood out for their strikingly rich immune environment and are heavily infiltrated by T cells, B cells, and macrophages. The results from the single-cell and deconvolution analyses confirmed subtype-specific immune microenvironments, which also allowed us to observe increased levels of natural killer (NK) and CD8+ T cells in Her2-enriched and Basal-like subtypes. In conclusion, our findings demonstrate significant differences in the immune tumor microenvironment between the established breast cancer molecular subtypes.  \nARTICLE HISTORY  \nReceived 11 July 2025 Revised 21 December 2025 Accepted 22 December 2025  \nKEYWORDS  \nBreast cancer; tumor microenvironment; immune cell spatial location; single cell  \nIntroduction  \nThe breast tumor microenvironment (TME) is complex and consists of distinct immune cell types and states. Understanding the cellular heterogeneity and the function of the immune microenvironment has become increasingly important, as it can influence clinical outcome and therapeutic response. 1,2  \nThe PAM50 classification is a modern molecular diagnosis that divides breast tumors into five subtypes: Luminal A, Luminal B, Basal-like, Her2-enriched, and Normal-like.3,4 The Luminal subtypes are often defined pathologically as estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (Her2) negative. Luminal B tumors tend to be more proliferative, exhibiting higher Ki-67 expression and a worse prognosis compared to Luminal A. The Her2-enriched subtype is usually ER and progesterone receptor (PgR) negative, Her2 receptor positive, and","cbCaitAEsNTIZTai","https://ap.wps.com/l/cbCaitAEsNTIZTai","pdf",5753304,16,"English","# Introduction\n## PAM50 breast cancer molecular subtypes\n# Methods and immune profiling approach\n## Multiplex immunohistochemistry\n## Single-cell RNA sequencing and deconvolution\n# Results across subtypes\n## Immune infiltration differences\n## NK and CD8+ T cell enrichment","[{\"question\":\"Which immune cells were evaluated across breast cancer subtypes in the study?\",\"answer\":\"The analysis included CD3+ T cells, tryptase+ mast cells, CD20+ B cells, CD68+ CD163+ macrophages, and CD66b+ granulocytes, revealing clear differences by subtype.\"},{\"question\":\"How did immune infiltration patterns differ between Luminal, Her2-enriched, and Basal-like tumors?\",\"answer\":\"Luminal tumors were relatively deprived of T and B cells with sparse to moderate macrophage infiltration. Her2-enriched tumors showed moderate immune presence, while Basal-like tumors had a strikingly rich immune environment heavily infiltrated by T cells, B cells, and macrophages.\"},{\"question\":\"What role did single-cell and deconvolution analyses play in the conclusions?\",\"answer\":\"Single-cell and deconvolution results confirmed that immune microenvironments are subtype-specific and supported observations such as increased natural killer (NK) and CD8+ T cells in Her2-enriched and Basal-like subtypes.\"}]","Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes | PDF",1790060763,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78135eb23653ff192490406ad6a77b96.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0328a44a2b07fa1203727e46dba7be18.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4ceff5f663b9fbf76f54c6601a722d3.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60df58f259eedc8903213b06ab8cdd40.webp",980,1306]